Background Gastric cancer is the fifth most common cancer worldwide. In" Western"
countries, most people are either diagnosed at an advanced stage, or develop a relapse …

STRUCTURE OF THE GUIDELINES The original guidelines described the management of
oesophageal and gastric cancer within existing practice. This paper updates the guidance to …

Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of
gastric cancers are adenocarcinomas, which are typically classified based on anatomic …

Importance Safe and effective therapies for untreated, advanced gastric/gastroesophageal
junction (G/GEJ) cancer remain an unmet need. Objective To evaluate the antitumor activity …

Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of
death from cancer in the world. Several advances have been made in the staging …

Chemotherapy-induced neutropaenia is a major risk factor for infection-related morbidity
and mortality and also a significant dose-limiting toxicity in cancer treatment. Patients …

Several gastrointestinal and gynecological malignancies have the potential to disseminate
and grow in the peritoneal cavity. The occurrence of peritoneal carcinomatosis (PC) has …

Background Although radical surgery remains the cornerstone of cure in resectable gastric
cancer, survival remains poor. Current evidence-based (neo) adjuvant strategies have …

Introduction An important component of treatment failure in gastric cancer (GC) is cancer
dissemination within the peritoneal cavity and nodal metastasis. Intraperitoneal …

Background A prospective randomized trial was conducted to compare the impact of
systemic chemotherapy versus multi‐modality therapy (complete cytoreductive surgery …